Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System
| Autor: | Elizabeth I. O. Garner, Janet Wittes, Terrance Ocheltree, Irina Krause, Joseph Chiodo, Michael Tuley, Jessica Case |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Adolescent Urology Equivalence Trials as Topic Levonorgestrel Administration Cutaneous Ethinyl Estradiol Body Mass Index Young Adult Contraceptive Agents In vivo Internal medicine Oximes Humans Medicine Pharmacology (medical) Adverse effect Cross-Over Studies Dose-Response Relationship Drug business.industry Norgestrel General Medicine Adhesion Rheumatology Confidence interval Drug Combinations Female business Contraceptive patch Body mass index Transdermal contraceptive medicine.drug |
| Zdroj: | Advances in Therapy. 36:3381-3389 |
| ISSN: | 1865-8652 0741-238X |
| Popis: | AG200-15, an investigational transdermal contraceptive delivery system or patch, is designed to be a low-dose, non-daily, combined hormonal contraceptive option for women. In this phase 1 study, the in vivo adhesion of the AG200-15 patch was compared to Xulane®, the only contraceptive patch available in the USA. This phase 1, randomized, open-label, single-dose, two-treatment, two-period crossover adhesion study compared the 7-day adhesion of the AG200-15 and Xulane contraceptive patches. Eighty-three women, ages 18 to 35 years old, with body mass index (BMI) ≥ 19 kg/m2 and |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink